RNA
Avidity Biosciences, Inc. Common Stock
$72.61
-0.03%
-0.02
Notify me if price changes either direction
Buy RNA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
10.9B
Enterprise value
9.1B
Trailing PE
-25.121107266436
Forward PE
-14.846383
PEG Ratio
-0.26336644714812
Enterprise to EBITDA
-14.963
Enterprise to revenue
436.706
Price to book MRQ
5.648926
Price to sales TTM
524.2026
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
20.9M
EBITDA
-609062016
Diluted EPS TTM
-4.19
Total Cash (MRQ)
1.9B
Current ratio (MRQ)
11.573
Operating Cash Flow (TTM)
-580539008
RNA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
